NRG Oncology Network Group Operations Center

NRG临床试验开发核心摘要 NRG肿瘤学（NRG）临床试验开发核心（核心）提供科学的 支持小组研究活动和倡议所需的领导和基础设施。 NRG拥有强大的临床试验开发设施，由医生研究人员领导， 统计人员和行政主任谁拥有一个杰出的数量和质量， 设计和指导复杂的多中心临床试验的知识和专业知识， 反映了集团的具体目标。核心与NRG的统计数据密切合作， 数据管理中心、NRG数据监测委员会（DMC）和NRG 征集、审查、批准和开发前瞻性临床试验的行政核心。 该计划致力于开发与NRG和NCI一致的临床试验 使命是在全球范围内实施高质量的临床和转化试验（主要是晚期试验）， 适时为此，核心调查员和工作人员与NCI-CTEP密切合作， NCTN的集中功能（例如，CTSU，CIRB）和其他NCTN集团。患者 核心委员会的职能包括倡导和关注多样性。NRG的临床试验 发展计划由其研究战略委员会领导，其成员包括： 国际公认的主席和副主席的NRG的癌症疾病网站和其他 在机构和网络小组研究方面经验丰富的科学委员会。 这些委员会的领导人和核心成员了解礼仪的重要性 开发、新研究者培训/指导、试验开展、完成和及时分析 并公布研究结果。这些医生研究者和核心管理人员 与NCTN的总体使命以及NRG的持续成功保持一致 肿瘤科

NRG Clinical Trials Development Core Abstract The NRG Oncology (NRG) Clinical Trials Development Core (Core) provides the scientific leadership and infrastructure necessary to support the group's research activities and initiatives. NRG has a robust facility for clinical trials development, led by physician-investigators, statisticians, and administrative directors who possess an outstanding quantity and quality of knowledge and expertise in designing and directing complex, multicenter clinical trials that reflect the specific aims of the group. The Core works closely with the NRG's Statistics and Data Management Center, the NRG Data Monitoring Committee (DMC), and the NRG Administrative Core in soliciting, reviewing, approving, and developing prospective clinical trials. The program is committed to developing clinical trials that are congruent with NRG's and NCI's mission to implement high-quality clinical and translational trials (primarily late phase trials) in a timely manner. To that end, the Core investigators and staff work closely with NCI-CTEP, the NCTN's centralized functions (e.g., CTSU, CIRB) and the other NCTN Groups. Patient advocates and attention to diversity are included in the Core's functions. NRG's clinical trials development program is led by its Research Strategy Committee, whose members are internationally recognized chairs and vice-chairs of NRG's cancer disease site and other scientific committees who have great experience in institutional and network group research. The leaders and core members of these committees understand the importance of protocol development, new investigator training/mentorship, trial conduct, completion and timely analysis and publication of study results. These physician investigators and the Core administrative staff are well aligned with the overall mission of the NCTN and the continued success of NRG Oncology.